CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
195 hedge funds and large institutions have $6.64B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% more funds holding
Funds holding: 119 → 195 (+76)
3% more call options, than puts
Call options by funds: $79.6M | Put options by funds: $77.1M
Holders
195
Holding in Top 10
11
Calls
$79.6M
Puts
$77.1M
Top Buyers
| 1 | +$280M | |
| 2 | +$232M | |
| 3 | +$117M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$81M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$73.1M |
Top Sellers
| 1 | -$591M | |
| 2 | -$203M | |
| 3 | -$69.4M | |
| 4 |
Millennium Management
New York
|
-$43.2M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$39.8M |